Dr Agarwal's merger vote: key dates for July 2026 meetings

What has been scheduled and why it matters

Dr. Agarwal's Eye Hospital Limited (AEHL) has scheduled meetings of its equity shareholders and unsecured creditors on July 02, 2026 to consider and approve a proposed Scheme of Amalgamation with Dr. Agarwal’s Health Care Limited (AHCL). The meetings are being convened under directions of the National Company Law Tribunal (NCLT), Chennai Bench. This step is part of the regulatory process required for a merger under Sections 230 to 232 of the Companies Act, 2013. The outcome of these meetings will determine whether the scheme can move forward for further statutory and regulatory approvals.

The company has also opened a remote e-voting window ahead of the meetings, allowing eligible voters to cast their votes electronically before the physical meetings. Alongside e-voting, shareholders and creditors can vote through polling papers at the venue on the day of the meetings. The NCLT has appointed key officials to conduct and verify the voting process.

NCLT Chennai order and the first motion milestone

The NCLT Chennai Bench allowed the joint First Motion Application filed by AEHL and AHCL for the proposed amalgamation. The order was pronounced on May 05, 2026 and was uploaded on May 11, 2026, as disclosed by the companies under Regulation 30. As part of the directions, the tribunal asked both companies to convene meetings of shareholders and creditors on July 02, 2026.

The bench that passed the order comprised Judicial Member Sanjiv Jain and Technical Member Venkataraman Subramaniam. The scheme, as described in the proceedings, provides for the amalgamation of AEHL into AHCL, transfer and reorganisation of share capital, issuance of shares to AEHL shareholders, and dissolution of AEHL without winding up. The companies have also stated that the scheme remains subject to receipt of all necessary statutory and regulatory approvals under applicable laws.

Venue, timing, and who attends which meeting

The meetings will be held at The Music Academy in Chennai. AEHL’s equity shareholder meeting is scheduled for 9:00 AM IST on July 02, 2026. The meeting of unsecured creditors is scheduled on the same day at 11:30 AM IST.

These meetings provide the formal forum to approve or reject the amalgamation scheme. For a scheme to proceed, approvals from the relevant stakeholder classes are typically required as per the directions and process under the Companies Act, 2013 and the NCLT’s order.

Remote e-voting window and physical voting on meeting day

AEHL has provided for remote e-voting as well as voting at the meeting venue. The remote e-voting facility opens on June 07, 2026 at 09:00 AM IST and concludes on July 01, 2026 at 05:00 PM IST. Stakeholders who choose not to use remote e-voting can vote by polling papers at the physical meetings on July 02, 2026.

The company has also dispatched physical letters carrying voting instructions for those whose email addresses are not registered. This ensures that eligible shareholders and creditors can access the voting process even if digital communication is not available.

Cut-off dates that determine voting eligibility

The eligibility to vote is linked to cut-off dates specified for each class. For shareholders, those whose names appear on the Register of Members or the Register of Beneficial Owners as on June 03, 2026 are eligible to vote. Separately, the notice cut-off date referenced for shareholders is May 22, 2026.

For unsecured creditors, the cut-off date mentioned for eligibility is December 31, 2025. These dates matter because they set the population entitled to participate in the approval process. Investors and creditors typically track these dates to confirm whether their holdings or claims are captured for voting.

Chairperson and scrutinizer appointed for the process

The NCLT has appointed Shri Kanwal Jeet Arora as the Chairperson and Shri Sriram Ananth V as the Scrutinizer for the meeting. The chairperson’s role is to oversee the conduct of the meeting, while the scrutinizer validates the voting process and results.

Such appointments are standard in tribunal-directed meetings, where the process must follow prescribed procedures, including notice, quorum, and voting mechanics. These roles are important for ensuring that the meeting outcomes are recorded and reported in line with the NCLT’s directions.

Scheme terms: share exchange ratio and board approval date

The merger scheme was approved by the boards on August 27, 2025, along with a share exchange ratio. Under the scheme, AHCL will issue 23 equity shares of Re. 1 each for every 2 equity shares of AEHL with a face value of Rs. 10 each. This ratio is a central term for AEHL shareholders because it defines the consideration they receive if the scheme is approved and implemented.

The scheme also provides for issuance of shares to AEHL shareholders and the dissolution of AEHL without winding up, as described in the NCLT proceedings. These are structural outcomes that reshape the corporate setup if the merger proceeds.

Key dates and meeting details at a glance

Regulatory pathway: what happens after these meetings

These meetings are an intermediate step in the amalgamation process. Even if shareholders and creditors approve the scheme, the scheme remains subject to further statutory and regulatory approvals as required under applicable laws. The companies have also indicated that they were awaiting the certified copy of the order, which would be made available on the company’s website.

The NCLT’s first motion order is a procedural milestone because it sets the process for collecting stakeholder approval. The next stages generally depend on the results of the meetings and the completion of the remaining legal and regulatory requirements.

Market impact and what investors can track

The immediate market relevance is procedural rather than operational, since the event is about voting and approvals. For investors, the key monitorables are the voting participation, the outcome of the shareholder and creditor meetings, and subsequent regulatory filings and tribunal steps.

The share exchange ratio is another core data point, because it defines how AEHL equity is proposed to be converted into AHCL equity under the scheme. Investors may also track updates on the scheme being subject to necessary statutory and regulatory approvals, as repeatedly highlighted in the disclosures around the NCLT direction.

Case reference and formal record

The NCLT matter is referenced as: Case Title: Dr. Agarwal’s Eye Hospital Limited with Dr. Agarwal’s Health Care Limited; Case Number: CA(CAA)/19(CHE)/2026; Citation: 2026 LLBiz NCLT(CHE) 449. These references help stakeholders locate the formal tribunal record associated with the first motion order.

Conclusion

AEHL’s July 02, 2026 meetings in Chennai and the June 07 to July 01 remote e-voting window form the key approval step in the proposed amalgamation with AHCL. The next developments depend on meeting outcomes and subsequent statutory and regulatory approvals, as indicated in the NCLT-directed process.